Newsroom

Newsroom

Press Releases

Date Title and Summary Additional Formats
September 15, 2021
Nuwellis, Inc. Announces Pricing of $8.7 Million Underwritten Public Offering of Common Stock
EDEN PRAIRIE, Minn. , Sept. 15, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today the pricing of an underwritten public offering of 3,483,120 shares of its common stock at a price to the public of $2.50 per share, for gross proceeds of approximately $8.7 million
September 14, 2021
Nuwellis, Inc. Announces Proposed Underwritten Public Offering of Common Stock
EDEN PRAIRIE, Minn. , Sept. 14, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today that it intends to offer shares of its common stock in an underwritten public offering.  All of the shares of common stock to be sold in the offering will be offered by the
September 14, 2021
Nuwellis, Inc. Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Sept. 14, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective September 13, 2021 , the independent directors approved an equity award under Nuwellis’ 2021 Inducement Plan, as a material inducement to an individual entering into employment
August 31, 2021
Nuwellis Inc. to Speak at Upcoming Investor Conferences
EDEN PRAIRIE, Minn. , Aug. 31, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, announced today that Nestor Jaramillo Jr ., Chief Executive officer, and George Montague , Chief Financial Officer, are
August 24, 2021
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Aug. 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective August 18, 2021 , the independent directors approved four equity awards under Nuwellis’ 2021 Inducement Plan, as material inducement to four individuals entering into employment
August 10, 2021
Nuwellis, Inc. Announces 35 Percent Increase in Revenue for Second Quarter 2021 Over Previous Year and Provides Company Update
EDEN PRAIRIE, Minn. , Aug. 10, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the second quarter ended June 30, 2021 , which included the following highlights: Reported record quarterly revenue of $2.5 million , a 35 percent increase compared to the prior
August 5, 2021
Nuwellis to Advance Treatment of Critically-Ill Children and Babies Under $1.7 Million NIH Grant
Funds will Support Creation of Life-Saving Pediatric Fluid Management Product EDEN PRAIRIE, Minn. , Aug. 05, 2021 (GLOBE NEWSWIRE) -- Critically-ill children and babies with kidney failure or who are dependent on artificial kidney support currently do not have enough therapeutic options.
July 27, 2021
Nuwellis, Inc. To Announce Second Quarter 2021 Financial Results on August 10, 2021
EDEN PRAIRIE, Minn. , July 27, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), announced today that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss
July 13, 2021
American Medical Association Issues New CPT Code for Nuwellis’ Aquadex Ultrafiltration
The newly classified code expands access to life-saving, novel fluid removal technology EDEN PRAIRIE, Minn. , July 13, 2021 (GLOBE NEWSWIRE) -- In an effort to increase the availability of life-saving ultrafiltration therapy to people experiencing fluid overload, the American Medical Association
July 6, 2021
Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare Conference
EDEN PRAIRIE, Minn. , July 06, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that, Nestor Jaramillo , Chief Executive officer, and George Montague , Chief Financial Officer, are scheduled
Displaying 1 - 10 of 36

Upcoming Events

More events are coming soon.
jump